|
| Exchange Received Time 01/12/2017 08:53:31 Exchange Disseminated Time 01/12/2017 08:53:37 Time Taken 00:00:06 | Dear Sirs,
Sub: Glenmark announces successful closure of the decentralised registration procedure (DCP) for generic Seretide® Accuhaler® in the Nordic region
With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.
Request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Glenmark Pharmaceuticals Limited
Harish Kuber
Company Secretary & Compliance Officer
|
|
|